ESC Heart Failure

ISSN 2055-5822 · Wiley · United States · active 2014–2026

Metrics

Scimago quartile (2025)
Q2
Cites per paper (2y)
5.2
SJR
0.835
h-index
81

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.

Data as of 18 October 2026 (venue index build).

Scimago Journal Rank 2025

In the Scimago Journal Rank 2025 edition, ESC Heart Failure is Q2 in Cardiology and Cardiovascular Medicine (#121 of 414 journals).

Scimago 2025 quartile and rank of ESC Heart Failure in each subject category
Subject categoryQuartileRank in category
Cardiology and Cardiovascular MedicineQ2#121 of 414
Cites per document (2 years, Scopus)
3.82
Documents indexed in 2025 (Scopus)
456

The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).

ESC Heart Failure is Q2 in Cardiology and Cardiovascular Medicine (2025 edition, #121 of 414 journals), with SJR 0.835 (Scimago) and an h-index of 81 (OpenAlex). Listed in DOAJ, Scopus, Web of Science, PubMed.

Is this the right journal for your paper?

The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.

Try the Journal Finder →

Responding time

Submission to first decision
28 days (avg)
Publisher-reported
Submission to acceptance
122 days (avg)
Publisher-reported
Acceptance to publication
29 days (avg)
Publisher-reported
Submission to publication
~10 wk
DOAJ self-reported
Acceptance rate
33%
Publisher-reported

Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.

Indexing & access

Indexed in
DOAJScopusWeb of SciencePubMed
Access status:
gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Article processing charge
Article processing charge (APC): €4,788 per accepted article (DOAJ). Fee waivers are available.

Official journal site →

Scope

heartfailuretreatmentmanagementcardiologycardiovascularmedicinefunctionriskfactorscardiacpacing

Frequently asked

Is ESC Heart Failure a predatory journal?

Our screening does not flag ESC Heart Failure. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.

Is ESC Heart Failure indexed in Scopus or Web of Science?

Per our venue index, ESC Heart Failure appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

What is the impact factor of ESC Heart Failure?

Papers in ESC Heart Failure are cited about 5.2 times each within two years of publication, and Scimago places it in Q2, with an h-index of 81. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.

What Scimago quartile is ESC Heart Failure (Q1, Q2, Q3, or Q4)?

In the Scimago Journal Rank 2025 edition, ESC Heart Failure is Q2 in Cardiology and Cardiovascular Medicine (#121 of 414 journals). Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; ESC Heart Failure is cited about 5.2 times per paper over two years, with an h-index of 81.

What is the Web of Science (JCR) quartile of ESC Heart Failure?

The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for ESC Heart Failure. The open equivalent is its Scimago quartile, Q2, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.

Is ESC Heart Failure open access?

Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.

What is the article processing charge (APC) to publish in ESC Heart Failure?

Article processing charge (APC): €4,788 per accepted article (DOAJ). Fee waivers are available. The exact charge can vary by article type and any fee waiver, so confirm the current amount on the journal's own site.

How long does ESC Heart Failure take to publish a paper?

Submission to first decision for ESC Heart Failure takes about 28 days (avg) — Publisher-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own.

What is the acceptance rate of ESC Heart Failure?

ESC Heart Failure reports an acceptance rate of about 33% — Publisher-reported. Acceptance rates vary by article type and change from year to year, and a publisher-stated figure is the journal's own, so treat it as indicative rather than a guarantee.

Ready to submit? Tools for your next paper

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Similar venues

Compare it with its peers: Ranked Cardiology and Cardiovascular Medicine journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.

Command palette

Jump anywhere, run any action.